New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management

New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management.

All Rx NSAIDs will carry a new boxed warning about GI and cardiovascular risk. You'll have to dispense a new Med Guide.

Celebrex (celecoxib) will also have a Medication Guide and boxed warning...plus clinical trial data on cardiovascular risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote